Skip to the page

Data / Form D filings / ProEncia Biotechnology Inc.

ProEncia Biotechnology Inc.: Form D filing

ProEncia Biotechnology Inc., a biotechnology company in Woodbury, MN, filed a Form D with the SEC in 2026. The latest, on August 26, 2026, reports $1.5 million sold of a $2 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9094 PRINCETON ROAD, Woodbury, MN, 55125
Phone
(763) 464-2812
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Minnesota
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2103044

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 26, 2026New notice$2,000,000$1,510,000$490,00014Oct 4, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tapos GhoshExecutive Officer, Director
Tarun GhoshDirector
Austin LoebExecutive Officer
Thomas HooverExecutive Officer

Other biotechnology companies in Minnesota that filed recently

Every Form D from the week of Aug 24, 2026 · All recent filings in Minnesota · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ProEncia Biotechnology Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.